Publication | Open Access
New Orally Active Serine Protease Inhibitors
32
Citations
0
References
1995
Year
Preclinical TherapeuticsAltmetric Attention ScorePharmacotherapyPharmaceutical ChemistryPre-clinical PharmacologyTranslational PharmacologyMolecular PharmacologyMedicinal ChemistryClinical TrialsAnti-cancer AgentProteomicsInhibitory ActivityProtease InhibitorsBiochemistrySocial Media PresenceDrug DevelopmentPharmacologyNatural SciencesClinical PharmacologyJ. MedMedicineDrug DiscoveryQuantitative Pharmacology
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTNew Orally Active Serine Protease InhibitorsKazuhiko Senokuchi, Hisao Nakai, Yoshisuke Nakayama, Yoshihiko Odagaki, Katsuhito Sakaki, Masashi Kato, Toru Maruyama, Toru Miyazaki, Hidenori Ito, Koumei Kamiyasu, Soon-ih Kim, Masanori Kawamura, and Nobuyuki HamanakaCite this: J. Med. Chem. 1995, 38, 14, 2521–2523Publication Date (Print):July 1, 1995Publication History Published online1 May 2002Published inissue 1 July 1995https://pubs.acs.org/doi/10.1021/jm00014a003https://doi.org/10.1021/jm00014a003research-articleACS PublicationsRequest reuse permissionsArticle Views309Altmetric-Citations24LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts